T-cell therapy (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-cell therapy (unspecified), covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer [Phase 1, Phase 2]